- Drug Name: Loqtorzi
- Generic Name: toripalimab
- Dosage Forms and Strengths: Injection: 240 mg/6 mL (40 mg/mL) solution in a single-dose vial
- Manufactured by: Coherus BioSciences, Inc.
LOQTORZI is a special medicine that helps fight a type of cancer in the nose and throat called nasopharyngeal carcinoma (NPC). Doctors use it in two different ways to help adults with this cancer. First, they give it along with two other medicines, cisplatin and gemcitabine, to people whose cancer has spread or come back after treatment. Second, they use LOQTORZI by itself for those whose cancer keeps growing after trying another treatment that included platinum. It helps stop the cancer from getting worse and gives hope to those who need more options for their treatment.
When used with cisplatin and gemcitabine, LOQTORZI is given through a vein (intravenously) every three weeks at a dose of 240 mg. If it’s used alone, the dosage is determined based on a person’s weight, and it’s given through a vein every two weeks at a rate of 3 mg per kilogram of body weight. For the first time, the medicine is infused slowly over 60 minutes. If everything goes well and there are no bad reactions during the first infusion, the following infusions can be a bit quicker, taking only 30 minutes. This helps make the treatment more convenient for patients.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.